LifeScience Vaccines

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide...

 November 25, 2022 | News

Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China

MVA-BN RSV, is being developed for the prevention of respiratory syncytial virus (RSV) in older adults. The vaccine incorporates five distinct RSV antigens...

 November 15, 2022 | News

YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine

PIKA COVID-19 vaccine is composed of PIKA adjuvant and a stable trimeric form of the recombinant SARS-CoV-2 spike (S) protein as the main antigen component...

 November 11, 2022 | News

EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine

This program is funded under CEPI's 2021 call for proposals to accelerate the development of broadly protective coronavirus vaccines, which will ...

 November 01, 2022 | News

Emmes (Global CRO) rapidly expands in India

Global CRO’s India office reports surging growth from Western, regional and local trial customers    Emmes – a global, full-se...

 October 28, 2022 | News

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

 October 26, 2022 | News

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

  CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...

 October 26, 2022 | News

T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness

Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure untreatable, age-related conditions, today presents interim pre-c...

 October 25, 2022 | News

U.S. FDA Grants EUA for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 October 24, 2022 | News

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the...

 October 13, 2022 | News

Sirnaomics Advances GalAhead(TM)-Based RNAi Therapeutics for Treatment of Complement-Related Diseases

 Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi t...

 August 29, 2022 | News

Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine

The phase III clinical trial of REC603 in China consists of three parts, i.e. the efficacy trial, the immuno-bridging trial in younger-age groups...

 August 11, 2022 | News

Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply

U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the JYNNEOS vaccine to allow healthcare providers to use the vaccine by i...

 August 10, 2022 | News

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...

 August 09, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in